Moderna's cancer vaccine trial results carry high stakes for the company.
Context
What happened: Moderna is set to reveal full Phase 3 trial data for its custom cancer treatment this weekend.
Why it matters: Moderna is one of the hottest stocks of the year because of this treatment, so a lot is riding on the data.
Key numbers: Full Phase 3 data are due this weekend.